What additional vaccination should be offered to a patient over the age of 60 who has quit smoking?

For patients over the age of 60, the zoster vaccine is highly recommended, especially for those who have quit smoking. This vaccine helps protect against herpes zoster, also known as shingles, which is caused by the reactivation of the varicella-zoster virus. As people age, the risk of developing shingles increases, and it can lead to serious complications, including postherpetic neuralgia, which causes severe pain.

Vaccination with the zoster vaccine significantly reduces both the incidence of shingles and the severity of the disease in those who do contract it. Given the age and health context of the patient, providing this vaccine would be a proactive measure to enhance their health and prevent potential complications associated with shingles.

The other options, while relevant in specific contexts, do not address the immediate preventive needs for a patient in this age group. For instance, additional doses of the pneumococcal vaccine are recommended based on specific health conditions or prior vaccination history, annual lung cancer screening is advised primarily for those at high risk based on smoking history and other factors, and tuberculin skin testing is generally not a routine vaccine or screening for older adults unless there are other risk factors for tuberculosis exposure. Thus, the zoster vaccine is the most appropriate